The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis
- PMID: 31498142
- PMCID: PMC6918899
- DOI: 10.3233/NRE-192792
The 2-minute walk test is not a valid method to determine aerobic capacity in persons with Multiple Sclerosis
Abstract
Background: Walking tests, like the 2-minute fast walk test, are simple, inexpensive performance-based tests, and therefore seem attractive to estimate the aerobic fitness in people with chronic diseases.
Objective: To determine the criterion validity of the 2-minute fast walk test for estimating aerobic capacity in patients with Multiple Sclerosis (MS), by comparing it with the peak oxygen uptake (VO2peak in mL/kg/min) as measured by Cardiopulmonary Exercise Testing (CPET) on a cycle ergometer.
Methods: The 2 min fast walk test was performed on a marked indoor trajectory, using a static start protocol. Aerobic capacity (VO2peak, in mL/kg/min) was derived from CPET on a cycle ergometer. Criterion validity was tested by means of Pearson's correlation coefficient and should be at least 0.70 for a good criterion validity of the 2 min walk test. Linear regression analysis was applied to more precisely estimate VO2peak.
Results: In total 141 people with severe MS-related fatigue (mean age 47.0 years (range 23-68 years), 73% women, median disease duration 7.8 years (range 0.3 - 28.7 years)) performed both tests. The distance walked in two minutes ranged from 52.0 to 290.0 m (mean 175.1 m, sd 44.9 m), while the VO2peak varied between 11.31 and 40.28 mL/kg/min (mean 22.52 mL/kg/min, sd 6.07 mL/kg/min). The correlation between the 2 min walk test and VO2peak was 0.441 (95% CI: 0.309-0.570). The absolute residual error in estimated VO2peak was 5.47 mL/kg/min.
Conclusions: Due to the poor correlation found between the 2 min walk test and VO2peak, the 2-min walk test cannot be recommended as a valid alternative for estimating aerobic capacity in persons with MS.
Keywords: 2 minute walk test; Exercise capacity; criterion validity; multiple sclerosis.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures



References
-
- Balady, G. J., Arena, R., Sietsema, K., Myers, J., Coke, L., Fletcher, G. F., Forman, D., Franklin, B., Guazzi, M., Gulati, M., Keteyian, S. J., Lavie, C. J., Macko, R., Mancini, D., & Milani, R. V. (2010). American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; & Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician’s Guide to cardiopulmonary exercise testing in adults: A scientific statement from the American Heart Association. Circulation, 122, 191–225. - PubMed
-
- Bernstein, M. L., Despars, J. A., Singh, N. P., Avalos, K., Stansbury, D. W., & Light, R. W. (1994). Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease. Chest, 105, 163–167. - PubMed
-
- Bland, J. M., & Altman, D. G., Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986(i), 307–310. - PubMed
-
- Cahalin, L. P., Mathier, M. A., Semigran, M. J., Dec, G. W., & DiSalvo, T. G. (1996). The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest, 110, 325–332. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical